Cardiology in the ER A Practical Guide Carlos Jerjes-Sánchez 123 Cardiology in the ER Carlos Jerjes-Sánchez Cardiology in the ER A Practical Guide Carlos Jerjes-Sánchez Instituto de Cardiología y Medicina Vascular TecSalud, Hospital Zambrano Hellion Escuela de Medicina y Ciencias de la Salud Tecnológico de Monterrey San Pedro Garza García Nuevo León México ISBN 978-3-030-13678-9 ISBN 978-3-030-13679-6 (eBook) https://doi.org/10.1007/978-3-030-13679-6 © Springer Nature Switzerland AG 2019 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland For my beloved family, my dear wife Alicia and my two dear children, Carlos and Alicia, thank you for accompanying me in this life and to the time we have spent together Preface The book Cardiology in the ER attempts to link advances made in the management of patients with cardiovascular emergencies. The main characteristic of the last decade was the acquisition of new knowledge and technologic advances to improve patients’ care in the emergency room. In this book, we cover the broad spectrum of cardiovascular emergencies and highlight a practical approach to patient assessment and therapy. The book was enriched with our 30-year experience in treating cardiovascular emergencies at large cardiology hospitals in Mexico, from 1982 to 1995 in the emergency room department in the Cardiology Hospital, National Medical Center, IMSS, Mexico City, and from 1996 to 2010 in the emergency room department in the Cardiology Hospital No. 34, IMSS, Monterrey City. In both hospitals, I had the opportunity to perform the first fast-track programs in cardiology hospitals on ST-elevation myocardial infarction and submassive and massive pulmonary embo- lism patients to perform systemic thrombolysis in <30 minutes and <90 minutes, respectively. Also, I had active participation in patient care and decision-making in the setting of different cardiovascular emergencies in all these years. Cardiology in the ER provides a current and comprehensive update of the most frequent clinical presentation symptoms (dyspnea, chest pain, and syncope) and acute cardiovascular events. The clinical spectrum of the acute vascular syndromes (acute coronary syndromes, acute aortic syndromes, and acute pulmonary embo- lism), cardiac tamponade, cardiogenic shock, hypertensive crisis, arrhythmias, as well as acute heart failure, cardiac arrest, and prosthetic valve dysfunction is fully explored. Finally, the chapter related to pacemaker emergencies presents current knowledge and gives to the emergency room physician a quick review of the com- plications, clinical diagnostic keys, high clinical suspicion signs, and possible treat- ments. Additionally, a brief section about the basis of pacing is included. Our contribution is targeted to a broad group of physicians, including cardiolo- gists, internists, and first-contact physicians involved in the emergency room patient care. In addition, it serves as a resource for medical students, interns, residents, and fellows. vii viii Preface A deep recognition to all coauthors for their contributions that made this book possible; especially Dr. David Rodriguez for the excellent coordination. We hope that this book enables physicians to make the best decisions for their patients in the field of cardiovascular emergencies. It is my profound hope that Cardiology in the ER will in some measure improve the quality of care for all patients in the emergency room. Finally, thanks to all those patients whom we were able to help but especially to those whom we could not. San Pedro Garza Gar cia, Carlos Jerjes-Sánchez, MD, FCCP, Nuevo León, Mexico FACC, MHSMC, FESC Contents 1 Chest Pain in the ER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1.1 The Scope of the Problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1.2 Prevalence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1.3 High-Clinical Suspicion for Cardiac-Related Causes of CP in the ER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 1.4 Chest Pain and Risk Factors for Acute Coronary Syndromes . . . . . 2 1.4.1 Pathophysiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 1.4.2 Clinical Presentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 1.4.3 Physical Examination. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 1.4.4 Electrocardiogram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 1.5 Imaging Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 1.5.1 Chest X-ray . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 1.5.2 Echocardiogram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 1.5.3 Immediate Exercise Stress Echocardiogram . . . . . . . . . . . . 8 1.5.4 Cardiac Computed Tomography (CCT) and Other Imaging Tests . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 1.6 Laboratory Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 1.6.1 Cardiac Biomarkers in the Context of Acute Coronary Syndromes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 1.6.2 Differential Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 1.6.3 Clinical Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 1.7 Additional Clinical Practice Takeaway . . . . . . . . . . . . . . . . . . . . . . 12 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 2 Dyspnea in the ER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 2.1 The Scope of the Problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 2.2 Prevalence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 2.3 High-Clinical Suspicion for Dyspnea of Cardiac Origin . . . . . . . . . 16 2.3.1 Pathophysiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 2.3.2 Clinical Presentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 2.3.3 Dyspnea Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 ix x Contents 2.3.4 Physical Examination. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 2.3.5 Electrocardiogram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 2.4 Imaging Diagnosis Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 2.4.1 Chest X-Ray . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 2.4.2 Echocardiogram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 2.4.3 Cardiac Computed Tomography . . . . . . . . . . . . . . . . . . . . . 24 2.4.4 Ventilation/Perfusion Lung Scan . . . . . . . . . . . . . . . . . . . . . 24 2.5 Laboratory Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 2.5.1 Cardiac Biomarkers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 2.5.2 Differential Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 2.6 Additional Clinical Practice Takeaway . . . . . . . . . . . . . . . . . . . . . . 28 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 3 Suspected Cardiovascular Syncope in the ER . . . . . . . . . . . . . . . . . . . 31 3.1 The Scope of the Problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 3.2 Prevalence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 3.3 Syncope Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 3.4 Pathophysiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 3.5 Clinical Presentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 3.5.1 Presyncope . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 3.5.2 Syncope . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 3.5.3 Main Clinical Characteristics . . . . . . . . . . . . . . . . . . . . . . . . 34 3.5.4 Risk Stratification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 3.6 Multimodal Diagnosis Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 3.7 Laboratory Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 3.7.1 Differential Diagnosis of Cardiac Syncope . . . . . . . . . . . . . 38 3.8 Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 3.8.1 Neurally Mediated Syncope . . . . . . . . . . . . . . . . . . . . . . . . . 38 3.8.2 Orthostatic Hypotension . . . . . . . . . . . . . . . . . . . . . . . . . . . 40 3.8.3 Cardiac Syncope . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 3.9 Additional Clinical Practice Takeaways . . . . . . . . . . . . . . . . . . . . . 41 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 4 Optimizing the Use of Biomarkers in the ER . . . . . . . . . . . . . . . . . . . . 43 4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 4.2 The Scope of the Problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 4.2.1 Pre-analytical Operating Characteristics . . . . . . . . . . . . . . . 44 4.2.2 Analytical Operating Characteristics . . . . . . . . . . . . . . . . . . 45 4.2.3 Clinical Operating Characteristics . . . . . . . . . . . . . . . . . . . . 45 4.2.4 Principles for the Proper Use of Cardiac Biomarkers at the ER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 4.3 Cardiac Troponins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 4.3.1 Physiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47 4.3.2 Pre-analytical Considerations . . . . . . . . . . . . . . . . . . . . . . . 47 4.3.3 Analytical Characteristics . . . . . . . . . . . . . . . . . . . . . . . . . . 49 4.3.4 Clinical Relevance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49 Contents xi 4.3.5 Clinical Conditions Associated with Increased Expression of cTn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50 4.3.6 Diagnostic Algorithms and Prediction Scores . . . . . . . . . . . 51 4.3.7 Foresight, Challenges, and Limitations at the ER . . . . . . . . 52 4.4 Natriuretic Peptides, Cardiac Stress, and Heart Failure . . . . . . . . . . 52 4.4.1 Physiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53 4.4.2 Pre-analytical Considerations . . . . . . . . . . . . . . . . . . . . . . . 53 4.4.3 Analytical Characteristics . . . . . . . . . . . . . . . . . . . . . . . . . . 54 4.4.4 Clinical Relevance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 4.4.5 Clinical Conditions Associated with Increased Expression of NP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56 4.4.6 Diagnostic Algorithms and Prediction Scores . . . . . . . . . . . 56 4.4.7 Foresight, Challenges, and Limitations at the ER . . . . . . . . 57 4.5 D-Dimer and Endogenous Fibrinolysis Activation . . . . . . . . . . . . . 57 4.5.1 Physiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58 4.5.2 Pre-analytical Considerations . . . . . . . . . . . . . . . . . . . . . . . 58 4.5.3 Analytical Characteristics . . . . . . . . . . . . . . . . . . . . . . . . . . 58 4.5.4 Clinical Relevance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60 4.5.5 Clinical Conditions Associated with Increased Expression of DD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61 4.5.6 Diagnostic Algorithms and Prediction Scores . . . . . . . . . . . 62 4.5.7 Foresight, Challenges, and Limitations at the ER . . . . . . . . 62 4.6 Bayesian Reasoning and Clinical Decision-Making . . . . . . . . . . . . 62 4.6.1 Rules of Decision-Making Based on Probabilities . . . . . . . 64 4.6.2 Pretest Probability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64 4.6.3 Posttest Probability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 4.6.4 Clinical Practice Takeaway . . . . . . . . . . . . . . . . . . . . . . . . . 65 4.7 Suggested Tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68 5 Acute Coronary Syndromes in the ER . . . . . . . . . . . . . . . . . . . . . . . . . 73 5.1 The Scope of the Problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73 5.2 Classification and Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73 5.3 Prevalence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76 5.4 Pathophysiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76 5.5 High Clinical Suspicion in ACS . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77 5.6 Risk Stratification. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78 5.7 Other Risk Considerations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81 5.7.1 Clinical Manifestations . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82 5.7.2 Differential Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83 5.8 Multimodal Diagnosis Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . 83 5.8.1 Electrocardiogram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83 5.8.2 Chest X-Ray . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87 5.9 Laboratory Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 5.9.1 Echocardiogram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89